Published : Aug-2017
No. of Pages : 189
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Surgical Mesh Overview 9
3 Products under Development 10
3.1 Surgical Mesh - Pipeline Products by Stage of Development 10
3.2 Surgical Mesh - Pipeline Products by Territory 11
3.3 Surgical Mesh - Pipeline Products by Regulatory Path 12
3.4 Surgical Mesh - Pipeline Products by Estimated Approval Date 13
3.5 Surgical Mesh - Ongoing Clinical Trials 14
4 Surgical Mesh - Pipeline Products under Development by Companies 15
4.1 Surgical Mesh Companies - Pipeline Products by Stage of Development 15
4.2 Surgical Mesh - Pipeline Products by Stage of Development 17
5 Surgical Mesh Companies and Product Overview 18
5.1 Acera Surgical, Inc. Company Overview 18
5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Admedus Ltd Company Overview 19
5.2.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Anika Therapeutics Inc Company Overview 20
5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Boston Scientific Corp Company Overview 21
5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Colorado Therapeutics, LLC Company Overview 22
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 CorMedix Inc Company Overview 23
5.6.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 DSM Biomedical BV Company Overview 24
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Ethicon US LLC Company Overview 28
5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Fibralign Corporation Company Overview 30
5.9.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Harbor MedTech Inc Company Overview 33
5.10.1 Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 John Hopkins University Company Overview 36
5.11.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Medisse BV (Inactive) Company Overview 37
5.12.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Medlinx Acacia Pte Ltd Company Overview 39
5.13.1 Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 Medtronic plc Company Overview 40
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Polyganics BV Company Overview 42
5.15.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42
5.16 PolyNovo Biomaterials Pty Ltd Company Overview 43
5.16.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.17 Proxy Biomedical Ltd Company Overview 44
5.17.1 Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Refine LLC Company Overview 45
5.18.1 Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Retectix, LLC Company Overview 46
5.19.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Revivicor Inc Company Overview 47
5.20.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.21 Samyang Biopharmaceuticals Corp Company Overview 48
5.21.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 Silver Bullet Therapeutics, Inc. Company Overview 49
5.22.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 Soft Tissue Regeneration Inc Company Overview 50
5.23.1 Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Teleflex Inc Company Overview 51
5.24.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Tepha Inc Company Overview 52
5.25.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.26 The Electrospinning Company Ltd Company Overview 53
5.26.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
5.27 University of Maryland Baltimore Company Overview 54
5.27.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54
5.28 University of South Florida Company Overview 55
5.28.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55
6 Surgical Mesh- Recent Developments 56
6.1 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 56
6.2 Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 57
6.3 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 63
6.4 Jul 21, 2017: Endo to Restructure Manufacturing Network 65
6.5 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 65
6.6 Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 66
6.7 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 66
6.8 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 67
6.9 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 69
6.10 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 70
6.11 Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 70
6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 71
6.13 May 25, 2017: BioLineRx Reports First Quarter 2017 Financial Results 74
6.14 May 15, 2017: Colorado Therapeutics Appoints Medtronic Executive John Lorbiecki as Chief Operating Officer in Advance of XI-S+ Launch 76
6.15 May 12, 2017: Integra LifeSciences launches SurgiMend MP Collagen Matrix for Hernia Repair 76
6.16 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 77
6.17 May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 77
6.18 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 80
6.19 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 83
6.20 May 03, 2017: Coloplast delivers satisfactory Q2 result 84
6.21 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 84
6.22 Apr 27, 2017: Tepha Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM 3D Surgical Scaffold 86
6.23 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 87
6.24 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 88
6.25 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 89
6.26 Apr 24, 2017: Proxy Biomedical Group Announces New Corporate Brand Aran Biomedical 90
6.27 Apr 24, 2017: Collagen Solutions: Consolidation of US R&D activities and Board change 91
6.28 Apr 23, 2017: Bard Announces First Quarter Results 91
6.29 Apr 20, 2017: Long-term study shows continuous improvement of quality of life following cystocele repair with alloplastic mesh implant 92
6.30 Apr 18, 2017: RTI Surgical Expands Line of Matrices in International Markets 93
6.31 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 94
6.32 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 95
6.33 Mar 31, 2017: B. Braun continues its sales and earnings growth 95
6.34 Mar 29, 2017: Tepha Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE 3D Surgical Scaffold 97
6.35 Mar 23, 2017: BioLineRx Reports Year End 2016 Financial Results 98
6.36 Mar 20, 2017: Collagen Solutions introduces new online sales initiative in the US 100
6.37 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 100
6.38 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 101
6.39 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 103
6.40 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 103
6.41 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 104
6.42 Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 105
6.43 Feb 24, 2017: Admedus Announces Half Yearly Report 108
6.44 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 110
6.45 Feb 23, 2017: MiMedx Announces 2016 Record Results 112
6.46 Feb 22, 2017: Change in the B. Braun Management Board 114
6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 114
6.48 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 117
6.49 Feb 20, 2017: ACERA Selected as One of the "Best University Startups 2016" by National Council of Entrepreneurial Tech Transfer 119
6.50 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.51 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.52 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 121
6.53 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 123
6.54 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 123
6.55 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 124
6.56 Jan 26, 2017: Bard Announces Fourth Quarter Results 125
6.57 Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 126
6.58 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 127
6.59 Jan 19, 2017: Collagen Solutions Team Strengthened with New Scientific Advisory Board Appointments 128
6.60 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 128
6.61 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 129
6.62 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 130
6.63 Dec 21, 2016: Endo Announces Appointments and Updates to Executive Management Team 131
6.64 Dec 20, 2016: FDA Approval for Endoform Plastics and Reconstructive Matrix 132
6.65 Dec 20, 2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer 133
6.66 Dec 19, 2016: Collagen Solutions Announces Interim Results for the six months ended 30 September 2016 133
6.67 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 134
6.68 Dec 15, 2016: W. L. Gore & Associates Receives Innovative Technology Designation from Vizient for GORE SYNECOR Biomaterial 135
6.69 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 136
6.70 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 136
6.71 Nov 22, 2016: BioLineRx Reports Third Quarter 2016 Financial Results 139
6.72 Nov 21, 2016: TELA Bio Announces Settlement of Litigation with LifeCell 141
6.73 Nov 16, 2016: Tepha Subsidiary, Galatea Surgical, Announces Presentation of GalaFLEX Surgical Scaffold Clinical Data at London Breast Meeting 142
6.74 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 142
6.75 Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 143
6.76 Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 144
6.77 Nov 03, 2016: DSM Q3 2016 Results 145
6.78 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 147
6.79 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 148
6.80 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 150
6.81 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 151
6.82 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 154
6.83 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 156
6.84 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 157
6.85 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 157
6.86 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 159
6.87 Oct 25, 2016: Bard Announces Third Quarter Results 159
6.88 Oct 21, 2016: Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs 160
6.89 Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 160
6.90 Oct 10, 2016: Long-term cystocele repair and improved quality of life 161
6.91 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 162
6.92 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 163
6.93 Sep 30, 2016: Hernia Mesh Lawsuit Filed on Behalf of Ethicon Physiomesh Patient Scheduled for January 2018 Trial, Bernstein Liebhard Reports 164
6.94 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 165
6.95 Sep 25, 2016: Admedus Strengthens Management Team 166
6.96 Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 166
6.97 Sep 19, 2016: Organogenesis Announces New Chief Financial Officer 167
6.98 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 168
6.99 Sep 13, 2016: FDA Clears Omega3-rich Fish Skin for Surgical Applications 169
6.100 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 169
6.101 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 170
6.102 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 170
6.103 Sep 01, 2016: Fibralign Announces Enrollment Initiated for Stanford-Led Clinical Trial for Breast Cancer-Related Lymphedema 171
6.104 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 172
6.105 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 172
6.106 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 173
6.107 Aug 18, 2016: Deceptive marketing of surgical transvaginal mesh leads to trouble for Johnson & Johnson 175
6.108 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 176
6.109 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 177
6.110 Aug 11, 2016: BioLineRx Names Philip A. Serlin as Chief Executive Officer 177
6.111 Aug 11, 2016: BioLineRx Reports Second Quarter 2016 Financial Results 178
6.112 Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 180
6.113 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance 182
7 Appendix 186
7.1 Methodology 186
7.2 About GlobalData 189
7.3 Contact Us 189
7.4 Disclaimer 189
1.1 List of Tables
Table 1: Surgical Mesh - Pipeline Products by Stage of Development 10
Table 2: Surgical Mesh - Pipeline Products by Territory 11
Table 3: Surgical Mesh - Pipeline Products by Regulatory Path 12
Table 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13
Table 5: Surgical Mesh - Ongoing Clinical Trials 14
Table 6: Surgical Mesh Companies - Pipeline Products by Stage of Development 15
Table 7: Surgical Mesh - Pipeline Products by Stage of Development 17
Table 8: Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 9: Surgical Mesh - Orthopedic Surgery - Product Status 18
Table 10: Surgical Mesh - Orthopedic Surgery - Product Description 18
Table 11: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 12: GyneCel - Product Status 19
Table 13: GyneCel - Product Description 19
Table 14: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 15: HYAFF Mesh - Product Status 20
Table 16: HYAFF Mesh - Product Description 20
Table 17: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21
Table 18: Next Generation Abdominal Mesh - Product Status 21
Table 19: Next Generation Abdominal Mesh - Product Description 21
Table 20: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 21: XI-S+ - Product Status 22
Table 22: XI-S+ - Product Description 22
Table 23: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 24: Taurolidine Surgical Mesh - Product Status 23
Table 25: Taurolidine Surgical Mesh - Product Description 23
Table 26: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24
Table 27: Bioadhesive Surgical Mesh - Tendon Repair - Product Status 24
Table 28: Bioadhesive Surgical Mesh - Tendon Repair - Product Description 24
Table 29: Meso BioMatrix - Breast Surgery - Product Status 25
Table 30: Meso BioMatrix - Breast Surgery - Product Description 25
Table 31: DSM Biomedical BV - Ongoing Clinical Trials Overview 26
Table 32: Meso BioMatrix - Breast Surgery - Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial 27
Table 33: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: GYNECARE Next Generation Pelvic Floor Repair Device - Product Status 28
Table 35: GYNECARE Next Generation Pelvic Floor Repair Device - Product Description 28
Table 36: GYNECARE PROLIFT Next Generation - Product Status 29
Table 37: GYNECARE PROLIFT Next Generation - Product Description 29
Table 38: Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 39: BioBridge Collagen Matrix - Secondary Lymphedema - Product Status 30
Table 40: BioBridge Collagen Matrix - Secondary Lymphedema - Product Description 30
Table 41: Fibralign Corporation - Ongoing Clinical Trials Overview 31
Table 42: BioBridge Collagen Matrix - Secondary Lymphedema - Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Vascularized Lymph Node Transfer for Upper Extremity Lymphedema 32
Table 43: Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 44: EPMatrix - Breast Reconstruction - Product Status 33
Table 45: EPMatrix - Breast Reconstruction - Product Description 33
Table 46: Surgical Mesh - Joint Repair - Product Status 34
Table 47: Surgical Mesh - Joint Repair - Product Description 34
Table 48: Surgical Mesh - Urogynecological Repair - Product Status 34
Table 49: Surgical Mesh - Urogynecological Repair - Product Description 35
Table 50: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 51: 3D Facial Reconstruction Pre-Form Mesh - Product Status 36
Table 52: 3D Facial Reconstruction Pre-Form Mesh - Product Description 36
Table 53: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
Table 54: Composite Hernia Mesh - Product Status 37
Table 55: Composite Hernia Mesh - Product Description 37
Table 56: PTMC Prolapse - Product Status 38
Table 57: PTMC Prolapse - Product Description 38
Table 58: Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 59: PVDV Hernia Mesh - Product Status 39
Table 60: PVDV Hernia Mesh - Product Description 39
Table 61: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 62: Hernia Repair Device - Product Status 40
Table 63: Hernia Repair Device - Product Description 40
Table 64: ProGrip Mesh - Product Status 41
Table 65: ProGrip Mesh - Product Description 41
Table 66: Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42
Table 67: Surgical Mesh - Product Status 42
Table 68: Surgical Mesh - Product Description 42
Table 69: PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 70: NovoFlex - Product Status 43
Table 71: NovoFlex - Product Description 43
Table 72: Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: ExtreMESH - Product Status 44
Table 74: ExtreMESH - Product Description 44
Table 75: Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Refine Support System - Product Status 45
Table 77: Refine Support System - Product Description 45
Table 78: Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Table 79: DuraStar Dural Substitue - Product Status 46
Table 80: DuraStar Dural Substitue - Product Description 46
Table 81: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 82: Hernia Repair Scaffold - Product Status 47
Table 83: Hernia Repair Scaffold - Product Description 47
Table 84: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48
Table 85: Absorbable Surgical Mesh - Product Status 48
Table 86: Absorbable Surgical Mesh - Product Description 48
Table 87: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 88: Galvanis Mesh - Product Status 49
Table 89: Galvanis Mesh - Product Description 49
Table 90: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 91: 3D Surgical Mesh - Breast Reconstruction - Product Status 50
Table 92: 3D Surgical Mesh - Breast Reconstruction - Product Description 50
Table 93: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 94: Double-Sided Hernia Mesh - Product Status 51
Table 95: Double-Sided Hernia Mesh - Product Description 51
Table 96: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 97: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Status 52
Table 98: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Description 52
Table 99: The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
Table 100: Bio-Synthetic Surgical Mesh - Product Status 53
Table 101: Bio-Synthetic Surgical Mesh - Product Description 53
Table 102: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54
Table 103: Hybrid Mesh - Product Status 54
Table 104: Hybrid Mesh - Product Description 54
Table 105: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55
Table 106: SiC Nanoparticle Impregnated Surgical Mesh - Product Status 55
Table 107: SiC Nanoparticle Impregnated Surgical Mesh - Product Description 55
Table 108: Glossary 188
1.2 List of Figures
Figure 1: Surgical Mesh - Pipeline Products by Stage of Development 10
Figure 2: Surgical Mesh - Pipeline Products by Territory 11
Figure 3: Surgical Mesh - Pipeline Products by Regulatory Path 12
Figure 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13
Figure 5: Surgical Mesh - Ongoing Clinical Trials 14
